Validation of 68Ge/68Ga generator processing by chemical purification for routine clinical application of 68Ga-DOTATOC

被引:90
作者
Asti, Mattia [1 ]
De Pietri, Giovanni [1 ]
Fraternali, Alessandro [1 ]
Grassi, Elisa [2 ]
Sghedoni, Roberto [2 ]
Floroni, Federica [2 ]
Roesch, Frank [3 ]
Versari, Annibale [1 ]
Salvo, Diana [1 ]
机构
[1] Santa Maria Nuova Hosp, Dept Nucl Med, Reggio Emilia, Italy
[2] Santa Maria Nuova Hosp, Dept Med Phys, Reggio Emilia, Italy
[3] Johannes Gutenberg Univ Mainz, Inst Nucl Chem, D-55128 Mainz, Germany
关键词
Ge-68/Ga-68; generator; postprocessing of eluates; cation-exchange chromotography; DOTATOC; PET;
D O I
10.1016/j.nucmedbio.2008.04.006
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction: Imaging of somatostatin receptor expressing tumors has been greatly enhanced by the use of Ga-68-DOTATOC and PET/CT. Methods: In this work, a purification method for the Ge-68/Ge-68 generator eluate and a method to produce Ga-68-DOTATOC suitable for clinical use were evaluated. The generator eluate was purified and concentrated on a cation-exchange cartridge in HCl/acetone media. The efficacy of this procedure in eliminating metal impurities from the Ga-68 soultion was investigated by ICP-Ms. The radiotracer quality was evaluated by radio-TLC, and gamma-ray spectrometry. Resutls: Ga-68-DOTATOC preparations (n=33) were carried out with a mean synthesis yield of 59.3 +/- 2.8% (not corrected for decay) and a batch activity ranging from >95% of the Fe(III), Zn(II) and Mn(II) were eliminated from the solution. Conclusions: Ga-68-DOTATOC produced with this method can be efficiently used in nuclear medicine departments for PET evaluations. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:721 / 724
页数:4
相关论文
共 14 条
  • [1] Radiolabelling DOTA-peptides with 68Ga
    Breeman, WAP
    de Jong, M
    de Blois, E
    Bernard, BF
    Konijnenberg, M
    Krenning, EP
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 (04) : 478 - 485
  • [2] Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours
    Buchmann, I.
    Henze, M.
    Engelbrecht, S.
    Eisenhut, M.
    Runz, A.
    Schaefer, M.
    Schilling, T.
    Haufe, S.
    Herrmann, T.
    Haberkorn, U.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (10) : 1617 - 1626
  • [3] A fully automated synthesis for the preparation of 68Ga-labelled peptides
    Decristoforo, Clemens
    Knopp, Roger
    von Guggenberg, Elisabeth
    Rupprich, Marco
    Dreger, Thorsten
    Hess, Andre
    Virgolini, Irene
    Haubner, Roland
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2007, 28 (11) : 870 - 875
  • [4] 68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors:: Comparison with somatostatin receptor scintigraphy and CT
    Gabriel, Michael
    Decristoforo, Clemens
    Kendler, Dorota
    Dobrozemsky, Georg
    Heute, Dirk
    Uprimny, Christian
    Kovacs, Peter
    Von Guggenberg, Elisabeth
    Bale, Reto
    Virgolini, Irene J.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (04) : 508 - 518
  • [5] Henze M, 2001, J NUCL MED, V42, P1053
  • [6] Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC:: preliminary data
    Hofmann, M
    Maecke, H
    Börner, AR
    Weckesser, E
    Schöffski, P
    Oei, ML
    Schumacher, J
    Henze, M
    Heppeler, A
    Meyer, GJ
    Knapp, WH
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (12) : 1751 - 1757
  • [7] Kowalski Jorg, 2003, Mol Imaging Biol, V5, P42, DOI 10.1016/S1536-1632(03)00038-6
  • [8] MARCHOL M, 1982, ION EXCHANGERS ANAL
  • [9] 68Ga-labelled DOTA-derivatised peptide ligands
    Meyer, GJ
    Mäcke, H
    Schuhmacher, J
    Knapp, WH
    Hofmann, M
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 (08) : 1097 - 1104
  • [10] Schinkel AFL, 2003, J NUCL MED, V44, P877